Also trades as: 0R02.L (LSE) · $vol 0M
VIVS NASDAQ
VivoSim Labs, Inc.
1W: -12.3%
1M: -29.8%
3M: -80.1%
YTD: -89.5%
1Y: -93.9%
$0.20
-0.01 (-5.35%)
Weekly Expected Move ±11.4%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
10 relationships10
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-11-19
Earliest Filing
2025-03-26
Latest Filing
partner: 8
acquirer: 2
Counterparties (Filed by VIVS)
10 relationshipsCompanies named in VIVS's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Eli Lilly and Company | LLY | acquirer | Acquired Organovo's FXR program and related assets for $10 million upfront plus potential milestones. | 2025-03-26 | View |
| Eli Lilly and Company | LLY | acquirer | Purchased Organovo Holdings' FXR program and related assets for $10 million upfront plus potential milestones. | 2025-02-25 | View |
| Cellink AB | — | partner | Counterparty in patent dispute and settlement agreement | 2022-02-28 | View |
| MatTek Incorporated | — | partner | Subsidiary of Cellink AB involved in IPR proceedings | 2022-02-28 | View |
| Visikol, Inc. | — | partner | Subsidiary of Cellink AB involved in IPR proceedings | 2022-02-28 | View |
| BICO Group AB | — | partner | Parent company of Cellink AB that entered settlement and license agreement | 2022-02-28 | View |
| MUSC Foundation for Research and Development | — | partner | Licensor of patents exclusively licensed to Organovo | 2022-02-28 | View |
| San Diego Inspire 2, LLC | — | partner | Landlord in lease amendment for expansion of premises | 2021-11-19 | View |
| Newmark Knight Frank | NMRK | partner | Broker representing the Landlord | 2021-11-19 | View |
| Cushman & Wakefield of San Diego, Inc. | CWK | partner | Broker representing the Tenant | 2021-11-19 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-21 | Delisting Notice; Exhibits | View | |
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-07-30 | Other Events; Exhibits | View | |
| 2026-07-24 | Delisting Notice; Other Events; Exhibits | View | |
| 2026-07-17 | Material Agreement; Unregistered Equity Sales; Other Events; Exhibits | Agreement | View |
| 2026-04-03 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2025-12-18 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-08-14 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-05-06 | Other Events; Financial Statements and Exhibits | View | |
| 2025-04-24 | Amendments to Articles of Incorporation or Bylaws; Regulation FD Disclosure; Other Events; Financial | View | |
| 2025-04-23 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-04-02 | Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta | View | |
| 2025-03-27 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-03-26 | Completion of Acquisition or Disposition of Assets; Departure/Election of Directors; Appointment of | Acquisition | View |
| 2025-03-21 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2025-03-19 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-03-06 | Other Events; Financial Statements and Exhibits | View | |
| 2025-02-25 | Entry into Material Definitive Agreement; Notice of Delisting or Transfer; Other Events; Financial S | Agreement | View |
| 2025-01-17 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2024-12-31 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR